{
    "id": "339e0417-4d1a-e168-e063-6294a90a50bb",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "name": "hydrocortisone and acetic acid",
    "organization": "Saptalis Pharmaceuticals, LLC",
    "effectiveTime": "20250425",
    "ingredients": [
        {
            "name": "BENZETHONIUM CHLORIDE",
            "code": "PH41D05744"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLENE GLYCOL DIACETATE",
            "code": "5Z492UNF9O"
        },
        {
            "name": "SODIUM ACETATE",
            "code": "4550K0SC9B"
        },
        {
            "name": "ACETIC ACID",
            "code": "Q40Q9N063P"
        },
        {
            "name": "HYDROCORTISONE",
            "code": "WI4X0X7BPJ"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        }
    ],
    "indications": "INDICATIONS AND USAGE: For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.",
    "contraindications": "CONTRAINDICATIONS: Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.",
    "warningsAndPrecautions": "WARNINGS: Discontinue promptly if sensitization or irritation occurs.PRECAUTIONS: Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear. PEDIATRIC USE: Safety and effectiveness in pediatric patients below the age of 3 years have not been established.",
    "adverseReactions": "ADVERSE REACTIONS: Stinging or burning may be noted occasionally; local irritation has occurred very rarely. To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1-Â­800-FDA-1088 or www.fda.gov/medwatch ."
}